Endotis Pharma

Endotis Pharma is a biopharmaceutical company dedicated to the discovery and development of small-glyco drugs (SGDs, heparin / heparan sulphate mimetics) for use in thrombosis, oncology and a range of other indications with several potential blockbuster drugs. Founded in february 2003, Endotis is a privately held company which currently employs 34 people between sites in Paris and Lille.

Endotis’ business model is to develop antithrombotic drugs in man until proof-of principle (oral anticoagulants) or Phase IIb dose finding (parenteral antithrombotics), and then partner them; while in other therapeutic areas such as oncology, partnering could take place once proof of concept in animal is demonstrated.
Type: NORMAL
Address: Parc Biocitech - 102 route de Noisy, 93230 Romainville
Website: www.endotis.com
Phone: +33 (0)1 48 46 43 91
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.